Evidence map›Paper›PMID 36305022›Full record

ArticlePathologica2022

Metastatic mucinous ovarian carcinoma simulating lung primary: an integrated diagnostic lesson.

Giuseppe Pelosi, Marco De Luca, Maria Cannone, Emanuela Balladore, Isabella Ricotti, Davide Toniolo, Matteo Incarbone

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathologica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Giuseppe PelosiDepartment of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Marco De LucaInter-hospital Pathology Division, Istituto di Ricovero e Cura a Carattere Scentifico - IRCCS MultiMedica, Milan, Italy.
Maria CannoneInter-hospital Pathology Division, Istituto di Ricovero e Cura a Carattere Scentifico - IRCCS MultiMedica, Milan, Italy.
Emanuela BalladoreInter-hospital Pathology Division, Istituto di Ricovero e Cura a Carattere Scentifico - IRCCS MultiMedica, Milan, Italy.
Isabella RicottiDivision of Pathologic Anatomy and Histology, Azienda Socio-Sanitaria Territoriale Rhodense - Presidio Ospedaliero di Rho, Rho, Italy.
Davide TonioloDivision of Medical Oncology and Hematology, Azienda Socio-Sanitaria Territoriale Rhodense - Presidio Ospedaliero di Rho, Rho, Italy.
Matteo IncarboneDivision of Thoracic Surgery, Istituto di Ricovero e Cura a Carattere Scentifico - IRCCS MultiMedica, Milan, Italy.
Istituti di Ricovero e Cura a Carattere Scientifico · ITMultiMedica · ITPresidio Ospedaliero · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We herein document a rare instance of primary mucinous ovarian carcinoma metastatic to the left lung, whose deceptive secondary derivation was already envisaged according to the spectacular thromboembolism involving small pulmonary vessels, thereby realizing a centrifugal and centripetal metastatizing loop. This presentation was indicative of dismal prognosis. A multimodal biomarker key approach is herein emphasized, which included close clinico-pathologic data integration.

Indexed as

Adenocarcinoma, MucinousOvarian NeoplasmsCarcinoma, Ovarian EpithelialDiagnosis, DifferentialFemaleHumansLungG12CKRASlungmucinous adenocarcinomaovary

Identifiers

PMID36305022
PMCPMC9614303
OpenAlexW4307446871

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.